Phio Pharma Analyst Ratings
Phio Pharma Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/16/2023 | 162.01% | HC Wainwright & Co. | → $6 | Reiterates | Buy → Buy |
| 06/14/2021 | 162.01% | HC Wainwright & Co. | $4 → $6 | Maintains | Buy |
| 08/05/2020 | 74.67% | HC Wainwright & Co. | → $4 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/16/2023 | 162.01% | HC Wainwright & Co. | → 6 美元 | 重申 | 購買 → 購買 |
| 2021 年 6 月 14 日 | 162.01% | HC Wainwright & Co. | 4 美元 → 6 美元 | 維護 | 購買 |
| 2020 年 5 月 8 日 | 74.67% | HC Wainwright & Co. | → 4 美元 | 啓動覆蓋開啓 | → 購買 |
What is the target price for Phio Pharma (PHIO)?
Phio Pharma（PHIO）的目標價格是多少？
The latest price target for Phio Pharma (NASDAQ: PHIO) was reported by HC Wainwright & Co. on August 16, 2023. The analyst firm set a price target for $6.00 expecting PHIO to rise to within 12 months (a possible 162.01% upside). 1 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年8月16日公佈了Phio Pharma（納斯達克股票代碼：PHIO）的最新目標股價。這家分析公司將目標股價定爲6.00美元，預計PHIO將在12個月內升至6.00美元（可能上漲162.01％）。去年有1家分析公司公佈了評級。
What is the most recent analyst rating for Phio Pharma (PHIO)?
分析師對Phio Pharma（PHIO）的最新評級是多少？
The latest analyst rating for Phio Pharma (NASDAQ: PHIO) was provided by HC Wainwright & Co., and Phio Pharma reiterated their buy rating.
Phio Pharma（納斯達克股票代碼：PHIO）的最新分析師評級由HC Wainwright & Co. 提供，Phio Pharma重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Phio Pharma (PHIO)?
Phio Pharma（PHIO）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Phio Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Phio Pharma was filed on August 16, 2023 so you should expect the next rating to be made available sometime around August 16, 2024.
分析師在進行了廣泛的研究（包括瀏覽公開財務報表、與Phio Pharma的高管和客戶交談以及聽取業績電話會議）後得出了股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。Phio Pharma的最後一次評級是在2023年8月16日提交的，因此您應該預計下一個評級將在2024年8月16日左右公佈。
Is the Analyst Rating Phio Pharma (PHIO) correct?
分析師對 Phio Pharma (PHIO) 的評級正確嗎？
While ratings are subjective and will change, the latest Phio Pharma (PHIO) rating was a reiterated with a price target of $0.00 to $6.00. The current price Phio Pharma (PHIO) is trading at is $2.29, which is within the analyst's predicted range.
儘管評級是主觀的，將會發生變化，但最新的Phio Pharma（PHIO）評級得到了重申，目標股價爲0.00美元至6.00美元。Phio Pharma（PHIO）目前的交易價格爲2.29美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。